BridgeBio Pharma, Inc. ( BBIO) - Key Metrics
BBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.14 | -$0.78 | -$1.14 | -$1.14 |
| 2026Q1 | $1 | -$0.84 | -$1.01 | -$1.01 |
| 2025Q4 | $0.78 | -$1 | -$0.29 | -$0.31 |
| 2025Q3 | $0.63 | -$0.96 | -$0.58 | -$0.58 |
| 2025Q2 | $0.58 | -$0.95 | -$0.42 | -$0.45 |
BBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -23.87 |
| 2026Q1 | 0% | -22.10 |
| 2025Q4 | 0% | -19.12 |
| 2025Q3 | 0% | -13.53 |
| 2025Q2 | 0% | -11.36 |
BBIO
Price: $79.86
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.56 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Market Capitalization: 16.4 billion